Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI

被引：2

作者：

Vavuranakis, Manolis ^{[1
,2
]}

Boudoulas, Konstantinos D. ^{[2
]}

Katsarou, Ourania ^{[1
]}

Vrachatis, Dimitrios A. ^{[1
]}

Kalogeras, Konstantinos I. ^{[1
]}

Papaioannou, Theodore G. ^{[1
]}

Siasos, Gerasimos ^{[1
]}

Oikonomou, Evangelos ^{[1
]}

Lazaros, George ^{[1
]}

Vavuranakis, Michael-Andreas ^{[1
]}

Deftereos, Spyridon ^{[3
,4
]}

Tousoulis, Dimitrios ^{[1
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, Dept Cardiol 1, Athens, Greece

[2] Ohio State Univ, Dept Cardiovasc Med, Columbus, OH 43210 USA

[3] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Cardiol 2, Athens, Greece

[4] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA

来源：

CURRENT PHARMACEUTICAL DESIGN | 2017年 / 23卷 / 09期

关键词：

ASD; LAA; PFO; transcatheter; warfarin; coumadin; antiplatelet; NOAC; LEFT ATRIAL APPENDAGE; PATENT FORAMEN OVALE; TRANSCATHETER OCCLUSION PLAATO; TRANSIENT ISCHEMIC ATTACK; 2010 ESC GUIDELINES; HIGH-RISK PATIENTS; PERCUTANEOUS CLOSURE; STROKE PREVENTION; PARADOXICAL EMBOLISM; ORAL ANTICOAGULANTS;

D O I：

10.2174/1381612822666161221143416

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Transcatheter interventions for structural heart disease represent an emerging field in interventional cardiology. Undoubtedly, there is an absolute necessity for antiplatelet and/or anticoagulation treatment prior, during and post such interventions. However, currently administered regimens are mainly based in expert consensus recommendations. In the present review we aim to summarize data regarding anti platelet and/or anticoagulation treatment in the following transcatheter structural heart interventions: left atrial appendage closure, atrial septal defect closure, patent foramen oval closure, paravalvular leak closure.

引用

页码：1328 / 1333

页数：6

共 50 条

[21] Anticoagulation and antiplatelet therapy in stable coronary artery disease: A multicenter survey
Kopin, David
Jones, W. Schuyler
Klein, Andrew
Barnes, Geoffrey D.
[J]. THROMBOSIS RESEARCH, 2019, 180 : 25 - 27
[22] Antiplatelet and anticoagulation therapy in microlaryngeal surgery
Francis, David O.
Dang, Jennifer H.
Fritz, Mark A.
Garrett, C. Gaelyn
[J]. LARYNGOSCOPE, 2014, 124 (04): : 928 - 934
[23] Dual or single antiplatelet therapy with anticoagulation?
Fox, Keith A. A.
[J]. LANCET, 2013, 381 (9872): : 1080 - 1081
[24] Antiplatelet therapy and anticoagulation in patients with hypertension
Griffin, G
[J]. AMERICAN FAMILY PHYSICIAN, 2005, 71 (05) : 897 - 899
[25] Antiplatelet and Anticoagulation Therapy in Vitreoretinal Surgery
Oh, Jaeryung
Smiddy, William E.
Kim, Sung Soo
[J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (06) : 934 - 939
[26] Bridging under Anticoagulation and Antiplatelet Therapy
Altiok, Ertunc
Almalla, Mohammad
[J]. PHLEBOLOGIE, 2022, 51 (01) : 37 - 50
[27] Antithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart Interventions
Caracciolo, Alessandro
Mazzone, Paolo
Laterra, Giulia
Garcia-Ruiz, Victoria
Polimeni, Alberto
Galasso, Salvatore
Saporito, Francesco
Carerj, Scipione
D'Ascenzo, Fabrizio
Marquis-Gravel, Guillaume
Giustino, Gennaro
Costa, Francesco
[J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
[28] Fetal interventions for structural heart disease
Schidlow, David N.
Freud, Lindsay
Friedman, Kevin
Tworetzky, Wayne
[J]. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2017, 34 (12): : 1834 - 1841
[29] Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?
Collet, Jean-Philippe
Montalescot, Gilles
[J]. EUROINTERVENTION, 2013, 9 : S43 - S47
[30] Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations
Magkoutis, Nikolaos A.
Fradi, Sabi
Azmoun, Alexandre
Ramadan, Ramsi
Ben Ouanes, Sami
Vavuranakis, Manolis
Vrachatis, Dimitrios A.
Papaioannou, Theodore G.
Tousoulis, Dimitrios
Ghostine, Said
[J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (13) : 1888 - 1895

← 1 2 3 4 5 →